CClinicalTrials.gg
Not yet recruitingNCT06900231CACDAPESUpdated May 1, 2026

Knowledge, Attitudes, and Beliefs About Musculoskeletal Pain Among Primary Care Health Professionals in Spain.

An observational study in Fear Avoidance, sponsored by Universitat de Lleida. Not yet recruiting at 1 site in Spain. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by Universitat de Lleida · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
300
Sex
All
01

Study summary

Pain is influenced by psychological and emotional factors, and healthcare professionals may unintentionally contribute to chronic disability by reinforcing fear and limiting normal activity. Patients with chronic pain often feel they lack adequate information to manage their condition.

This study aims to:

  • Assess primary care professionals' knowledge of pain neurophysiology in Spain.
  • Evaluate their attitudes and beliefs about chronic low back pain.
  • Examine their fear-avoidance beliefs related to pain. A cross-sectional study will gather data from primary care providers. The results will help guide educational strategies and policies to improve musculoskeletal pain management. This will be the first study in Spain to analyze these aspects among primary care professionals.
Read the detailed description

Background: Pain is a multifactorial experience where psychological and emotional factors influence the transition from acute to chronic pain, prognosis, and the adoption of inappropriate self-management strategies. In addition to psychological and emotional factors, healthcare professionals can contribute to the development of chronic disabilities in their patients by promoting hypervigilance and restricting normal activities, potentially reinforcing or altering patients' perceptions, leading to limited mobility. Existing scientific literature suggests that patients with chronic pain often feel they do not receive sufficient information from healthcare professionals that could help them better understand and manage pain, thereby improving their quality of life.

Objectives:

  1. To assess the current knowledge of pain neurophysiology among primary care professionals (medicine, physiotherapy, nursing, nutrition, and psychology) in Spain.
  2. To evaluate attitudes and beliefs about chronic low back pain among primary care professionals (medicine, physiotherapy, nursing, nutrition, and psychology) in Spain.
  3. To examine fear-avoidance beliefs related to pain among primary care professionals (medicine, physiotherapy, nursing, nutrition, and psychology) in Spain.

Methodology: A cross-sectional descriptive study will be conducted to collect information from primary care health professionals (medicine, physiotherapy, psychology, nutrition, and nursing) in Spain, focusing on their current knowledge, attitudes, and beliefs about musculoskeletal pain.

Applicability: This study will provide valuable insights into the current state of knowledge, attitudes, and beliefs about musculoskeletal pain among primary care health professionals in Spain. The findings will guide future educational interventions and policy recommendations to improve the management of musculoskeletal pain in primary care settings in Spain.

Relevance: Scientifically, this will be the first study to evaluate the knowledge of primary care health professionals in Spain regarding pain neurophysiology, attitudes and beliefs about chronic low back pain, and fear-avoidance attitudes.

02

Conditions studied

  • Fear Avoidance

Keywords

  • Pain Management
  • Primary Health Care
  • Musculoskeletal Pain
  • Health Professionals
  • Fear-Avoidance
  • Pain Neurophysiology Knowledge
03

In context

Agnosia

1,190 studies on the registry are indexed under Agnosia; 508 are open to participants now.

This study's planned enrollment of 300 is above the median of 120 across 147 observational studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

Universitat de Lleida is the lead sponsor of 33 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Professionals in medicine, physiotherapy, nursing, psychology, and nutrition working in Primary Care Centers in Spain

Inclusion criteria

  • Graduates in medicine or residents specializing in family and community medicine.

Graduates in physiotherapy. Graduates in nursing or residents specializing in family and community nursing. Graduates in psychology. Graduates in nutrition.

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
300 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Pain Neurophysiology Knowledge Questionnaire

    The questionnaire consists of 19 questions that require true, false, or undecided answers, with a maximum score of 19 points. Higher scores mean better knowledge.

    Time frame: One-time assessment at enrollment

Secondary outcomes

  1. HC-PAIRS

    The questionnaire consists of 15 statements on a 7-point Likert scale (1 = completely disagree, 4 = neither agree nor disagree, and 7 = completely agree), with a maximum score of 105 points. Higher scores indicate a greater degree of beliefs about the relationship between chronic pain, functional limitation, and disability.

    Time frame: One-time assessment at enrollment

  2. Fear-Avoidance believes

    The questionnaire is divided into two subscales, FABQ-Physical Activity (questions 1-5) and FABQ-Work (questions 6-16), and consists of a total of 16 statements that require responses on a 6-point Likert scale (0 = completely disagree and 6 = completely agree), with a maximum score of 96 points. Higher scores indicate a greater degree of fear-avoidance beliefs.

    Time frame: One-time assessment at enrollment

07

Study locations

1 site
  • Universitat de Lleida
    Lleida, 25198, Spain
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06900231
Lead sponsor
Universitat de Lleida
Responsible party
Francesc Valenzuela Pascual (Associated professor, Universitat de Lleida) — Principal investigator
First posted
Mar 28, 2025
Start date
Jun 2026 (estimated)
Primary completion
Nov 2026 (estimated)
Completion
Mar 2027 (estimated)
Last update
May 1, 2026

Study contacts

Fran Valenzuela-Pascual, Dr.
Contact
fran.valenzuela@udl.cat
+34 973 702 459
Fran Valenzuela-Pascual, Dr.
principal investigator · Universitat de Lleida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion